SelectQuote, Inc. (SLQT) Stock Analysis

A tech-enabled Medicare broker with a best-in-class Senior segment is trying to reinvent itself into a recurring healthcare platform—while a DOJ False Claims Act lawsuit and heavy leverage make outcomes brutally binary.

Overview

SelectQuote (SLQT) is a tech-enabled, direct-to-consumer insurance distribution platform focused on complex senior-focused insurance and an expanding healthcare services ecosystem. It earns commissions as an intermediary (no underwriting/claims risk) and recognizes revenue under ASC 606 by booking an estimated constrained lifetime commission value at policy inception—creating front-loaded revenue recognition and sensitivity to persistency/tail adjustments. Operations are organized into three main segments: (1) **Senior** (Medicare Advantage/Med Supp plus ancillary products), the economic engine tied to AEP volumes and renewal persistency; (2) **Healthcare Services** (SelectRx pharmacy + chronic care/patient management), the strategic pivot aimed at recurring engagement and improved revenue quality; and (3) **Life**, the legacy business providing term/final expense products and steadier cash flow. The company has intentionally deemphasized Auto & Home to concentrate resources on higher-margin senior and healthcare opportunities. The investment setup is defined by strong Senior unit economics and an ambitious healthcare pivot, offset by leverage, reimbursement/counterparty dependency, and a major DOJ legal overhang.

Read the full SelectQuote, Inc. research report

Loading the interactive SLQT dashboard…